Diode Laser Safe, Effective for Treating Facial Skin Laxity

This article originally appeared here.
Share this content:
Diode Laser Safe, Effective for Treating Facial Skin Laxity
Diode Laser Safe, Effective for Treating Facial Skin Laxity

MONDAY, July 20, 2015 (HealthDay News) -- An 810- and 940-nm diode laser is safe and efficacious for treating facial skin laxity, according to a study published online July 15 in the Journal of Cosmetic Dermatology.

Nataya Voravutinon, M.D., from the Ministry of Public Health in Bangkok, Thailand, and colleagues examined the efficacy and safety of an 810- and 940-nm diode laser for treating facial skin laxity. The authors enrolled 30 patients in the study, with facial skin laxity grading scale II to IV. Patients underwent four treatment sessions over three-week intervals.

The researchers identified significant improvement in laxity of facial skin with the Cutometer MPA 580 F3 and R7 parameters at one and three months after complete treatment, respectively. At one and six months after treatment, physician assessment showed significant improvement in the laxity scale. Mild pain or minor adverse events were reported by approximately 10 percent of patients. Patient satisfaction was high, with 98 percent of patients expressing satisfaction with treatment.

"In conclusion, our study suggests that a diode laser (810 and 940 nm) is safe and may be an effective treatment for facial skin tightening," the authors write. "Maintenance treatment every two to three months may be the optimum interval for maintaining the results."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »